Table 4.
Hazard ratios for progression to Arnold–Hilgartner stage ≥ IV
| Univariate | Multivariable | |||||||
|---|---|---|---|---|---|---|---|---|
| HR | 95% CI | p | HR | 95% CI | p | |||
| Joint | ||||||||
| Elbow | Reference | Reference | ||||||
| Knee | 0.40 | 0.22 | 0.74 | 0.003 | 0.66 | 0.38 | 1.17 | 0.156 |
| Ankle | 1.86 | 1.16 | 2.98 | 0.009 | 0.91 | 0.56 | 1.50 | 0.720 |
| Arnold–Hilgartner stage at initiation of regular prophylaxis | ||||||||
| 0 | Reference | Reference | ||||||
| I | 13.12 | 6.14 | 28.04 | < 0.001 | 14.95 | 6.60 | 33.82 | < 0.001 |
| II | 13.72 | 6.99 | 26.94 | < 0.001 | 11.84 | 5.48 | 25.56 | < 0.001 |
| III | 42.59 | 25.26 | 71.80 | < 0.001 | 34.47 | 18.12 | 65.60 | < 0.001 |
| Age at first visit to our institute | ||||||||
| < 6 | Reference | Reference | ||||||
| 6– < 12 | 2.80 | 0.55 | 14.34 | 0.216 | 2.45 | 0.60 | 9.91 | 0.210 |
| 12– < 18 | 9.42 | 1.95 | 45.55 | 0.005 | 2.63 | 0.68 | 10.23 | 0.162 |
| ≥ 18 | 16.28 | 3.23 | 82.18 | 0.001 | 2.03 | 0.43 | 9.44 | 0.369 |
| Regular prophylaxis at first visit to our institute | ||||||||
| No | Reference | Reference | ||||||
| Yes | 0.44 | 0.28 | 0.68 | < 0.001 | 0.54 | 0.32 | 0.90 | 0.019 |
| Laterality | ||||||||
| Right | Reference | Reference | ||||||
| Left | 0.80 | 0.58 | 1.11 | 0.187 | 0.91 | 0.58 | 1.42 | 0.675 |
Univariate and multivariable Cox analyses of factors associated with progression to hemophilic arthropathy, defined as reaching Arnold–Hilgartner stage ≥ IV. The multivariable model included joint site, Arnold–Hilgartner stage at initiation of regular prophylaxis, age at first visit to our institute, regular prophylaxis status at first visit to our institute, and laterality. Cox models were estimated using cluster-robust standard errors with participant as the clustering variable
HA hemophilic arthropathy, HR hazard ratio, CI confidence interval